Condition: Breast Adenocarcinoma · Breast Cancer Stage IV · Breast Cancer, Metastatic · Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PALMARES-2 is a retrospective/prospective, observational, multicenter, population-based study, aiming at providing real-world evidences on HR+/HER2- aBC patients treated with first-line CDK4/6i plus ET. The present study has the objective to collect data coming from different sources, i.e. RWD, medical images and biological samples, from patients treated with CDK4/6i as first-line of therapy for HR+/HER2- aBC. In consideration of the complexity of data collected and different objectives of the study, this master protocol foresees different sub-studies, which encompasses different methodologies for data collection, data extraction and analyses.
This description comes directly from the study's public registry record.
Claudio Vernieri, M.D., Ph.D. · +390223903066 · claudio.vernieri@istitutotumori.mi.it
Always discuss trial participation with your own doctor first.
| Centro di Riferimento Oncologico IRCCS | Aviano, Italy | Recruiting |
| Azienda Socio Sanitaria Territoriale degli Spedali Civili | Brescia, Italy | Recruiting |
| Humanitas Istituto Clinico Catanese | Catania, Italy | Recruiting |
| ASST Lariana - Ospedale Sant'Anna | Como, Italy | Recruiting |
| ASST Ospedale Maggiore | Cremona, Italy | Recruiting |
| Azienda Ospedaliero Universitaria Careggi | Florence, Italy | Recruiting |
| Ospedale San Martino | Genova, Italy | Recruiting |
| Istituto Tumori della Romagna IRST IRCCS | Meldola, Italy | Recruiting |
| Fondazione IRCCS Ca' Granda Ospedale Maggiore | Milan, Italy | Recruiting |
| IEO Istituto Europeo di Oncologia | Milan, Italy | Recruiting |
| IRCCS Ospedale San Raffaele | Milan, Italy | Recruiting |
| Ospedale ASST Fatebenefratelli Sacco | Milan, Italy | Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06805812